Advanced Biomed Inc. Common Stock
ADVB | NASDAQ
$6.29
-$0.25 (-3.82%)
At close: Sep 21, 2026, 3:59 PM ET
$6.47
+$0.18 (+2.86%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Fiscal Quarter Period Ending | Q3 2026 Mar 30, 2026 | Q2 2026 Dec 30, 2025 | Q1 2026 Sep 29, 2025 | Q4 2025 Jun 29, 2025 | Q3 2025 Mar 30, 2025 | Q2 2025 Dec 30, 2024 | Q1 2025 Sep 29, 2024 | Q4 2024 Jun 29, 2024 | Q3 2024 Mar 30, 2024 | Q2 2024 Dec 30, 2023 | Q1 2024 Sep 29, 2023 | Q4 2023 Jun 29, 2023 | Q3 2023 Mar 30, 2023 | Q2 2023 Dec 30, 2022 | Q1 2023 Sep 29, 2022 | Q4 2022 Jun 29, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 294.79 | 465.94 | n/a | 2.09K | n/a | 679.77 | n/a | n/a | 2.38K | n/a | n/a | n/a | n/a | 2.32K | n/a | 3.89K |
Gross Profit | -294 | -465.94 | n/a | -2.09K | n/a | -679.77 | n/a | n/a | -2.38K | n/a | n/a | n/a | n/a | -2.32K | n/a | -3.89K |
Operating Income | -519.84K | -12.78K | -523.91K | -39.26K | -762.74K | -8.66K | -520.03K | -704.61K | -23.19K | -651.3K | -440.25K | -1.02M | -790.23K | -27.2K | -408.62K | -36.79K |
Interest Income | n/a | 296.60 | 448 | 307.96 | n/a | 475.50 | 10 | 33.41K | 104 | 19.97K | 14 | 21.28K | -17.92 | 224 | 443 | n/a |
Pretax Income | -488.94K | 225.6K | -386.9K | -22.72K | -1.38M | -17.92K | -265.58K | -809.39K | -42.08K | -145.35K | -771.32K | -1.68M | -518.11K | -12.29K | -1.15M | -91.73K |
Net Income | -488.94K | 220.95K | -386.9K | -22.72K | -1.38M | -28.07K | -265.58K | -809.39K | -42.08K | -145.35K | -771.32K | -1.68M | -518.11K | -12.29K | -1.15M | -91.73K |
Selling & General & Admin | 276.61K | 6.31K | 260.6K | 29.59K | 438.77K | 1.41K | 311.03K | 177.01K | 13.2K | 435.9K | 244.13K | 498.47K | 553.42K | 6.7K | 240.83K | 13.39K |
Research & Development | 243.23K | 6K | 235.99K | 7.58K | 250.46K | 6.57K | 181.7K | 209.11K | 7.62K | 188.39K | 169.19K | 488.17K | 208.17K | 18.18K | 116.61K | 19.52K |
Other Expenses | n/a | -0.03 | 27.32K | -0.15 | 73.51K | 0 | 27.29K | 318.49K | 27.17K | 27.01K | 26.93K | 32.53K | 28.64K | 24.4K | 51.18K | 129.74K |
Operating Expenses | 519.84K | 12.31K | 523.91K | 37.17K | 762.74K | 7.98K | 520.03K | 704.61K | 20.81K | 651.3K | 440.25K | 1.02M | 790.23K | 24.88K | 408.62K | 32.9K |
Interest Expense | 112 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 58 |
Selling & Marketing Expenses | 7.22K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 519.84K | 12.78K | 523.91K | 39.26K | 762.74K | 8.66K | 520.03K | 704.61K | 23.19K | 651.3K | 440.25K | 1.02M | 790.23K | 27.2K | 408.62K | 36.79K |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 1.28M | 1.08M | 1.08M | 1.08M | 1.02M | 1M | 1.08M | 1M | 1.08M | 1.08M | 1.08M | 1.08M | 1.08M | 1.08M | 1.08M | 1.08M |
Shares Outstanding (Diluted) | 1.28M | 1.08M | 1.08M | 1.08M | 1.02M | 1M | 1.08M | 1M | 1.08M | 1.08M | 1.08M | 1.08M | 1.08M | 1.08M | 1.08M | 1.08M |
EPS (Basic) | -0.38 | 0.20 | -0.01 | -0.02 | -0.04 | -0.03 | -0.01 | -0.04 | -0.04 | 0 | -0.02 | -0.05 | -0.02 | -0.01 | -0.03 | -0.08 |
EPS (Diluted) | -0.38 | 0.20 | -0.01 | -0.02 | -0.04 | -0.03 | -0.01 | -0.04 | -0.04 | 0 | -0.02 | -0.05 | -0.02 | -0.01 | -0.03 | -0.08 |
EBITDA | -479.5K | -12.31K | -475.92K | -37.17K | -528.77K | -7.98K | -417.81K | -386.12K | -39.69K | -577.94K | -350.94K | -852.18K | -758.87K | -24.88K | -244.11K | -32.9K |
EBIT | -488.83K | -12.78K | -523.91K | -39.26K | -762.74K | -8.66K | -520.03K | -704.61K | -42.07K | -651.3K | -440.25K | -1.02M | -790.23K | -27.2K | -408.62K | -36.79K |
Depreciation & Amortization | 9.33K | 465.94 | 47.99K | 2.09K | 233.97K | 679.77 | 102.22K | 318.49K | 2.38K | 73.37K | 89.31K | 166.99K | 31.36K | 2.32K | 164.51K | 3.89K |
Add to Watchlist
Select watchlists to add or remove ADVB